Valeant CEO sees new drug pricing environment ahead
Home/businessNews/ Valeant CEO sees new drug pricing environment ahead
Valeant CEO sees new drug pricing environment ahead
(Reuters) – Valeant Pharmaceuticals International Inc , which has been criticized for raising drug prices and is being investigated by the U.S. government, predicted on Monday that lower price increases are ahead for the whole industry.